Capital Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $217K | Sell |
414
-24
| -5% | -$12.6K | ﹤0.01% | 645 |
|
|
2025
Q1 | $278K | Buy |
438
+134
| +44% | +$84.9K | 0.01% | 568 |
|
|
2024
Q4 | $217K | Sell |
304
-11
| -3% | -$7.85K | ﹤0.01% | 597 |
|
|
2024
Q3 | $331K | Buy |
315
+20
| +7% | +$21K | 0.01% | 482 |
|
|
2024
Q2 | $310K | Buy |
295
+3
| +1% | +$3.16K | 0.01% | 483 |
|
|
2024
Q1 | $281K | Sell |
292
-3
| -1% | -$2.89K | 0.01% | 496 |
|
|
2023
Q4 | $259K | Buy |
295
+7
| +2% | +$6.16K | 0.01% | 504 |
|
|
2023
Q3 | $237K | Sell |
288
-18
| -6% | -$14.8K | 0.01% | 513 |
|
|
2023
Q2 | $220K | Sell |
306
-5
| -2% | -$3.59K | 0.01% | 492 |
|
|
2023
Q1 | $256K | Buy |
311
+24
| +8% | +$19.7K | 0.01% | 467 |
|
|
2022
Q4 | $207K | Sell |
287
-11
| -4% | -$7.93K | 0.01% | 526 |
|
|
2022
Q3 | $205K | Buy |
+298
| New | +$205K | 0.01% | 495 |
|
|
2022
Q2 | – | Sell |
-308
| Closed | -$215K | – | 590 |
|
|
2022
Q1 | $215K | Buy |
+308
| New | +$215K | 0.01% | 541 |
|
|
2016
Q1 | – | Sell |
-575
| Closed | -$312K | – | 441 |
|
|
2015
Q4 | $312K | Buy |
+575
| New | +$312K | 0.03% | 318 |
|